243 related articles for article (PubMed ID: 4795072)
1. Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.
Wikler A
Adv Biochem Psychopharmacol; 1973; 8(0):399-414. PubMed ID: 4795072
[No Abstract] [Full Text] [Related]
2. The search for the psyche in drug dependence. A 35-year retrospective survey.
Wikler A
J Nerv Ment Dis; 1977 Jul; 165(1):29-40. PubMed ID: 17651
[No Abstract] [Full Text] [Related]
3. Behavioral pharmacology of narcotic antagonists.
Mello NK
NIDA Res Monogr; 1978; (19):126-41. PubMed ID: 218104
[No Abstract] [Full Text] [Related]
4. The theoretical basis of narcotic addiction treatment with narcotic antagonists.
Wikler A
NIDA Res Monogr; 1976 Sep; (9):119-22. PubMed ID: 1004530
[No Abstract] [Full Text] [Related]
5. Addiction and the community. (Narcotic substitution therapy).
Taylor WJ; Chambers CD; Bowling CE
Int J Clin Pharmacol; 1972 Apr; 6(1):28-39. PubMed ID: 4625924
[No Abstract] [Full Text] [Related]
6. Certain theoretical and practical considerations involved in evaluating the overall abuse potential of opiate agonists and antagonists.
Fraser HF
Adv Biochem Psychopharmacol; 1973; 8(0):439-53. PubMed ID: 4604198
[No Abstract] [Full Text] [Related]
7. Psychological approaches to opiate dependence and self-administration by laboratory animals.
Schuster CR
Fed Proc; 1970; 29(1):2-5. PubMed ID: 4983813
[No Abstract] [Full Text] [Related]
8. XXI. Interaction of physical dependence and classical and operant conditioning in the genesis of relapse.
Wikler A
Res Publ Assoc Res Nerv Ment Dis; 1968; 46():280-7. PubMed ID: 4881462
[No Abstract] [Full Text] [Related]
9. Subjective effects of narcotic antagonists.
Haertzen CA
Adv Biochem Psychopharmacol; 1973; 8(0):383-98. PubMed ID: 4795096
[No Abstract] [Full Text] [Related]
10. Arylpyrrolidines as narcotic antagonists.
McCarthy DA
Adv Biochem Psychopharmacol; 1973; 8(0):145-55. PubMed ID: 4211813
[No Abstract] [Full Text] [Related]
11. Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20,740, ARC II-c-3).
Martin WR; Fraser HF; Gorodetzky CW; Rosenberg DE
J Pharmacol Exp Ther; 1965 Dec; 150(3):426-36. PubMed ID: 5322320
[No Abstract] [Full Text] [Related]
12. What's happening in hard-drug rehabilitation?
Walls RT; Gulkus SP
Rehabil Lit; 1973 Jan; 34(1):2-6. PubMed ID: 4683507
[No Abstract] [Full Text] [Related]
13. Conditioned suppression by a stimulus associated with nalorphine in morphine-dependent monkeys.
Goldberg SR; Schuster CR
J Exp Anal Behav; 1967 May; 10(3):235-42. PubMed ID: 4964349
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of drug dependence. Implications of a conditioning theory for research and treatment.
Wikler A
Arch Gen Psychiatry; 1973 May; 28(5):611-6. PubMed ID: 4700675
[No Abstract] [Full Text] [Related]
15. Development, extinction and reinstatement of morphine withdrawal-induced conditioned place aversion in rats.
Li Y; Liu X; Chen H; Deng H; Xiang X; Chen H; Hao W
Addict Biol; 2007 Sep; 12(3-4):470-7. PubMed ID: 17678507
[TBL] [Abstract][Full Text] [Related]
16. Animal-human correlates of narcotic dependence: a brief review.
Stimmel B; Glick SD
Am J Psychiatry; 1978 Jul; 135(7):821-5. PubMed ID: 96703
[TBL] [Abstract][Full Text] [Related]
17. Assays of antagonistic activity of narcotic antagonists in man.
Gorodetzky CW
Adv Biochem Psychopharmacol; 1973; 8(0):291-7. PubMed ID: 4604130
[No Abstract] [Full Text] [Related]
18. Clinical pharmacology of narcotic antagonists.
O'Brien CP; Greenstein R; Ternes J; Woody GE
Ann N Y Acad Sci; 1978; 311():232-40. PubMed ID: 369432
[TBL] [Abstract][Full Text] [Related]
19. 28. Methadone maintenance and its implication for theories of narcotic addiction.
Dole VP; Nyswander ME
Res Publ Assoc Res Nerv Ment Dis; 1968; 46():359-66. PubMed ID: 5723803
[No Abstract] [Full Text] [Related]
20. Demonstration of tolerance to and physical dependence of N-allylnormorphine (nalorphine).
Martin WR; Gorodetzky CW
J Pharmacol Exp Ther; 1965 Dec; 150(3):437-42. PubMed ID: 5322321
[No Abstract] [Full Text] [Related]
[Next] [New Search]
